Smoking ban led to 2% cut in MI admissions
By Tom Moberly, 09 June 2010
Emergency hospital admissions for MI fell by over 2% in the year after the smoking ban was introduced in England.
Dr Anne Gilmore and colleagues from University of Bath examined data on emergency hospital admissions in patients aged over 18 from July 2002 to September 2008. They found there were 1,200 fewer emergency admissions a year in the 12 months after the ban was introduced, equivalent to a fall of 2.4%.
Writing in the BMJ, the researchers said: 'Given the large number of MI events per year, even the relatively small reduction seen in England has important public health benefits.'
The researchers compared data from the five-year period before the ban on smoking in public places began on 1 July 2007 with data from the 12 months after its introduction. They adjusted their data to take into account changes in seasonal temperature and population size as well as underlying trends in admissions.
- Related Drug Categories
- MI, LVD
- Related MIMS Tables
- Anti-Anginal Preparations, Summary by Pharmacological Class
Additional Information

Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Newly qualified GP's dr-locums £70 an hour plus, Nationwide
- Full Time Partner (9 sessions) Charnwood Community Medical Group Equal share partner, Loughborough, LEICS
- Locum GP Meddoc Locums £600-£800 A day, London & Essex
Most read
- Health secretary says GPs have 'ethical duty' to save NHS costs
- GPs face 'outcomes targets overload', patient group warns
- LMCs Conference 2012 - Live Blog
- QOF errors trigger £1,000 top ups and clawbacks
- Women to be screened later for cervical cancer in Scotland and Wales
- LMCs conference 2012 - Full coverage
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.







